Latest News & Features
Big Pharma
There have been two significant references on issues that have been "left hanging" by the Court of Justice of the European Union in the last spate of decisions, says Paul England, senior associate at Taylor Wessing, in a video interview with LSIPR. 21 March 2017
Americas
Dow Agrosciences has secured attorneys’ fees from Bayer in a patent dispute, after Bayer failed in its appeal to the US Court of Appeals for the Federal Circuit. 20 March 2017
Americas
Allergan Pharmaceuticals and genome-editing company Editas Medicine have entered into a strategic research and development agreement over CRISPR technology. 20 March 2017
Americas
Biotech company Pacific Biosciences, of California, has filed a complaint against UK-based Oxford Nanopore Technologies for alleged patent infringement. 17 March 2017
Americas
AstraZeneca and Zydus Pharmaceuticals have entered into a settlement agreement over a patent dispute centring on heartburn drug Nexium. 17 March 2017
Asia
There is an urgent need for an effective global legal regime to prevent bio piracy, according to Rita Teaotia, commerce secretary of India. 16 March 2017
Americas
Dow Pharmaceutical Sciences and Valeant Pharmaceuticals have sued Teva and its subsidiary Actavis for patent infringement of Onexton (clindamycin phosphate and benzoyl peroxide), a treatment for acne. 16 March 2017
Americas
IP management company CPA Global has agreed to pay $5.6 million to medical diagnostic company Run Them Sweet as part of a settlement agreement in a class action lawsuit. 15 March 2017
Americas
Mylan has entered a settlement with Genentech and its parent company, Roche, in relation to patents for cancer drug Herceptin. 15 March 2017
Americas
President Trump’s decision to pull the US out of the Trans-Pacific Partnership trade deal may have particularly pernicious consequences for the pharmaceutical and biotechnology industries, writes Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff. 15 March 2017